• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

晚期卵巢癌中所选内含子的甲基化

Methylation of the Selected Introns in Advanced-Stage Ovarian Carcinomas.

作者信息

Szewczuk Wiktor, Szewczuk Oksana, Czajkowski Krzysztof, Gromadka Robert, Man Yan-Gao, Wałędziak Maciej, Semczuk Andrzej

机构信息

Department of Pathology, Military Institute of Medicine, Warsaw, Poland.

Department of Gynecology and Gynecologic Oncology, Military Institute of Medicine, Warsaw, Poland.

出版信息

J Cancer. 2024 May 30;15(13):4040-4046. doi: 10.7150/jca.94945. eCollection 2024.

DOI:10.7150/jca.94945
PMID:38947384
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11212084/
Abstract

Advanced-stage ovarian cancer (OC) is among the most fatal female genital tract neoplasms worldwide. Although different genetic mechanisms have been shown to be involved in ovarian carcinogenesis, the role of introns methylation is still unresolved. We performed methylation analysis of introns 1, 3, and 4 of the to identify patterns in primary stage III OCs, corresponding metastases, and healthy tissues. The study involved samples of paraffin-embedded tissues obtained from 80 patients with stage III OCs, who underwent surgery at the Department of Gynecology and Gynecologic Oncology of the Military Institute of Medicine in Warsaw, Poland. Altogether, 40 serous-type G2/3 OCs and 40 endometrioid-type G2/3 OCs were included. From the same patient, metastatic and normal tissues were simultaneously analyzed. As a control group, 80 tissue samples were collected from patients after bariatric operations. Human ovarian cancer A2780 cell line was also investigated. Total genomic DNA was isolated from paraffin-embedded tissue blocks and the methylation analysis was performed by bisulfite DNA conversion, DNA amplification with specific primers, cloning, and DNA sequencing. All of the samples of intron 1 of were un-methylated in OCs, metastatic tissues, and in healthy tissues from the same patient. Also, no methylation of intron 1 was detected in cells from the human A2780 ovarian cancer cell line and in all samples from control group. In all samples, introns 3 and 4 of the were methylated in primary tumors, metastatic tissue, and in healthy tissue from the same patient, in human A2780 ovarian cell line, and in DNA samples from healthy patients. None of the clinicopatholocal features was related to the introns methylation status. Our data on introns methylation sheds new light on the mechanism of p53 activity for a better understanding of cancer biology. The study suggests the existence of an additional regulation rule of activity that involves demethylation-methylation mechanisms. Methylation at introns 3 and 4 may also overall help in protecting against damage by viral restrictases or viral DNA integration.

摘要

晚期卵巢癌(OC)是全球最致命的女性生殖道肿瘤之一。尽管已显示不同的遗传机制参与卵巢癌的发生,但内含子甲基化的作用仍未明确。我们对[具体基因名称]的内含子1、3和4进行甲基化分析,以确定原发性III期OC、相应转移灶和健康组织中的模式。该研究涉及从80例III期OC患者获取的石蜡包埋组织样本,这些患者在波兰华沙军事医学研究所妇产科和妇科肿瘤学系接受了手术。总共纳入了40例浆液性G2/3 OC和40例子宫内膜样G2/3 OC。从同一患者同时分析转移组织和正常组织。作为对照组,从接受减肥手术的患者中收集了80个组织样本。还对人卵巢癌A2780细胞系进行了研究。从石蜡包埋组织块中分离出总基因组DNA,并通过亚硫酸氢盐DNA转化、用特异性引物进行DNA扩增、克隆和DNA测序进行甲基化分析。[具体基因名称]内含子1的所有样本在OC、转移组织以及同一患者的健康组织中均未甲基化。此外,在人A2780卵巢癌细胞系的细胞以及对照组的所有样本中均未检测到[具体基因名称]内含子1的甲基化。在所有样本中,[具体基因名称]的内含子3和4在原发性肿瘤、转移组织、同一患者的健康组织、人A2780卵巢细胞系以及健康患者的DNA样本中均发生甲基化。没有任何临床病理特征与[具体基因名称]内含子甲基化状态相关。我们关于[具体基因名称]内含子甲基化的数据为p53活性机制提供了新的线索,以更好地理解癌症生物学。该研究表明存在一种涉及去甲基化 - 甲基化机制的[具体基因名称]活性的额外调控规则。内含子3和4处的甲基化也可能总体上有助于保护[具体基因名称]免受病毒限制酶或病毒DNA整合的损伤。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3dc8/11212084/84343d2dfad5/jcav15p4040g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3dc8/11212084/962c8384a35f/jcav15p4040g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3dc8/11212084/ca822663c22a/jcav15p4040g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3dc8/11212084/84343d2dfad5/jcav15p4040g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3dc8/11212084/962c8384a35f/jcav15p4040g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3dc8/11212084/ca822663c22a/jcav15p4040g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3dc8/11212084/84343d2dfad5/jcav15p4040g003.jpg

相似文献

1
Methylation of the Selected Introns in Advanced-Stage Ovarian Carcinomas.晚期卵巢癌中所选内含子的甲基化
J Cancer. 2024 May 30;15(13):4040-4046. doi: 10.7150/jca.94945. eCollection 2024.
2
Clinical aspects of TP53 gene inactivation in diffuse large B-cell lymphoma.弥漫性大 B 细胞淋巴瘤中 TP53 基因失活的临床方面。
BMC Med Genomics. 2019 Mar 13;12(Suppl 2):35. doi: 10.1186/s12920-019-0484-9.
3
Allelic loss at TP53 in metastatic human endometrial carcinomas.转移性人类子宫内膜癌中TP53基因的等位基因缺失。
Clin Exp Metastasis. 2009;26(7):789-96. doi: 10.1007/s10585-009-9278-3. Epub 2009 Jun 30.
4
Nutlin-3a: A Potential Therapeutic Opportunity for TP53 Wild-Type Ovarian Carcinomas.Nutlin-3a:TP53野生型卵巢癌的潜在治疗契机
PLoS One. 2015 Aug 6;10(8):e0135101. doi: 10.1371/journal.pone.0135101. eCollection 2015.
5
Methylation of death-associated protein kinase in ovarian carcinomas.卵巢癌中死亡相关蛋白激酶的甲基化
Int J Gynecol Cancer. 2006 Jan-Feb;16 Suppl 1:195-9. doi: 10.1111/j.1525-1438.2006.00506.x.
6
Damage-inducible intragenic demethylation of the human TP53 tumor suppressor gene is associated with transcription from an alternative intronic promoter.人类TP53肿瘤抑制基因的损伤诱导型基因内去甲基化与来自一个替代性内含子启动子的转录相关。
Mol Carcinog. 2016 Dec;55(12):1940-1951. doi: 10.1002/mc.22441. Epub 2015 Dec 16.
7
TP53 mutations are common in all subtypes of epithelial ovarian cancer and occur concomitantly with KRAS mutations in the mucinous type.TP53 突变在所有上皮性卵巢癌亚型中都很常见,并且与黏液型中的 KRAS 突变同时发生。
Exp Mol Pathol. 2013 Oct;95(2):235-41. doi: 10.1016/j.yexmp.2013.08.004. Epub 2013 Aug 18.
8
Clinicopathologic analysis of low-stage sporadic ovarian carcinomas: a reappraisal.低分期散发性卵巢癌的临床病理分析:再评价。
Am J Surg Pathol. 2013 Mar;37(3):356-67. doi: 10.1097/PAS.0b013e318272ff19.
9
miR-7 expression in serous ovarian carcinomas.浆液性卵巢癌中miR-7的表达
Anticancer Res. 2015 Apr;35(4):2423-9.
10
Differential analysis of ovarian and endometrial cancers identifies a methylator phenotype.卵巢癌和子宫内膜癌的差异分析确定了一种甲基化表型。
PLoS One. 2012;7(3):e32941. doi: 10.1371/journal.pone.0032941. Epub 2012 Mar 5.

本文引用的文献

1
DNA methylation and cancer: transcriptional regulation, prognostic, and therapeutic perspective.DNA甲基化与癌症:转录调控、预后及治疗前景
Med Oncol. 2023 Jan 5;40(2):71. doi: 10.1007/s12032-022-01943-1.
2
Cancer of the ovary, fallopian tube, and peritoneum: 2021 update.卵巢、输卵管及腹膜癌:2021年更新
Int J Gynaecol Obstet. 2021 Oct;155 Suppl 1(Suppl 1):61-85. doi: 10.1002/ijgo.13878.
3
Epigenetic Attire in Ovarian Cancer: The Emperor's New Clothes.表观遗传学在卵巢癌中的作用:皇帝的新装。
Cancer Res. 2020 Sep 15;80(18):3775-3785. doi: 10.1158/0008-5472.CAN-19-3837. Epub 2020 May 7.
4
DNA Methylation Cancer Biomarkers: Translation to the Clinic.DNA甲基化癌症生物标志物:向临床转化
Front Genet. 2019 Nov 14;10:1150. doi: 10.3389/fgene.2019.01150. eCollection 2019.
5
Epigenetics in cancer: a promising path to follow?癌症中的表观遗传学:一条值得追寻的充满希望的道路?
Clin Chem Lab Med. 2019 Jun 26;57(7):927-931. doi: 10.1515/cclm-2019-0010.
6
TP53 mutations in epithelial ovarian cancer.上皮性卵巢癌中的TP53突变
Transl Cancer Res. 2016 Dec;5(6):650-663. doi: 10.21037/tcr.2016.08.40.
7
The Putative Role of Alterations and p53 Expression in Borderline Ovarian Tumors - Correlation with Clinicopathological Features and Prognosis: A Mini-Review.改变和p53表达在卵巢交界性肿瘤中的假定作用——与临床病理特征及预后的相关性:一篇综述
J Cancer. 2017 Aug 22;8(14):2684-2691. doi: 10.7150/jca.19691. eCollection 2017.
8
Epidemiology of ovarian cancer: a review.卵巢癌流行病学综述
Cancer Biol Med. 2017 Feb;14(1):9-32. doi: 10.20892/j.issn.2095-3941.2016.0084.
9
Whole genome DNA methylation: beyond genes silencing.全基因组DNA甲基化:超越基因沉默
Oncotarget. 2017 Jan 17;8(3):5629-5637. doi: 10.18632/oncotarget.13562.
10
Assessing mutant p53 in primary high-grade serous ovarian cancer using immunohistochemistry and massively parallel sequencing.利用免疫组织化学和大规模平行测序评估原发性高级别浆液性卵巢癌中的突变型p53
Sci Rep. 2016 May 18;6:26191. doi: 10.1038/srep26191.